Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer. Shakfa, N., Li, D., Conseil, G., Lightbody, E. D, Wilson-Sanchez, J., Hamade, A., Chenard, S., Jawa, N. A, Laight, B. J, Afriyie-Asante, A., & others Journal for Immunotherapy of Cancer, 11(4):e006170, 2023.
bibtex   
@article{shakfa2023cancer,
  title={Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer},
  author={Shakfa, Noor and Li, Deyang and Conseil, Gwenaelle and Lightbody, Elizabeth D and Wilson-Sanchez, Juliette and Hamade, Ali and Chenard, Stephen and Jawa, Natasha A and Laight, Brian J and Afriyie-Asante, Afrakoma and others},
  journal={Journal for Immunotherapy of Cancer},
  volume={11},
  number={4},
  pages={e006170},
  year={2023}
}

Downloads: 0